
About Shanghai Majorbio Pharmaceutical Technology
Shanghai Majorbio Pharmaceutical Technology is a Healthcare company based in Shanghai (China) founded in 2009. Provider of genome sequencing and genomic technology services. Its chief executive, as recorded, is Ming Wei. Its website majorbio.com draws about 53 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Genomics Services and Sequencing. Its competitors include HitGen, Novogene Corporation and BGI; 2 of its 3 listed competitors have raised funding.
Company details
Shanghai Majorbio Pharmaceutical Technology was founded in 2009 and is based in Shanghai, China. Operations focus on the life sciences sector, where high-throughput sequencing, biological information analysis, and research into clinical diagnostic kits are conducted. Genome sequencing services are extended to support pharmaceutical and biotechnology applications in the region.
- Headquarters Shanghai, China
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website majorbio.com
- Investors
Funding Insights of Shanghai Majorbio Pharmaceutical Technology
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Shanghai Majorbio Pharmaceutical Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2018 | Series C | β | β |
1 investors in total: 1 institutional.
Investors in Shanghai Majorbio Pharmaceutical Technology
Shanghai Majorbio Pharmaceutical Technology has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Tianjin Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| tjvcm.com |
Investor details for Shanghai Majorbio Pharmaceutical Technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Shanghai Majorbio Pharmaceutical Technology
1 people are tracked at Shanghai Majorbio Pharmaceutical Technology (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ming Wei | CEO | Leadership |
Complete people profiles for Shanghai Majorbio Pharmaceutical Technology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Shanghai Majorbio Pharmaceutical Technology
2 dated milestones of Shanghai Majorbio Pharmaceutical Technology across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Shanghai Majorbio Pharmaceutical Technology is founded.
- Funding First funding round.
Competitors of Shanghai Majorbio Pharmaceutical Technology
Shanghai Majorbio Pharmaceutical Technology has 3 listed competitors in our database, 2 of them funded. They include HitGen, Novogene Corporation and BGI.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hitgen.com | 2012 | Lanzhou, China | $39.11M | DNA-encoded libraries are developed for drug discovery applications. | ||
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| bgi.com | 1999 | Shenzhen, China | 25 | BGI is engaged in genomics and precision medicine solutions. |
Detailed competitors of Shanghai Majorbio Pharmaceutical Technology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Shanghai Majorbio Pharmaceutical Technology
The website of Shanghai Majorbio Pharmaceutical Technology (majorbio.com) receives about 53.3K visits a month.
- Monthly visits53.3K
▼ 24.9% vs previous month
Websites whose visitors overlap most with Shanghai Majorbio Pharmaceutical Technology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| personalbio.cn | 100% | 2.8K | #5,438,979 | View details | |
bioincloud.tech | bioincloud.tech | 99% | #1,221,637 | β | |
| biomarker.com.cn | 96% | 1.8K | #9,298,532 | View details | |
| nature.com | 94% | 33.6M | #1,922 | View details | |
| diacarta.com | 94% | 3.3K | #5,559,886 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 39 similar websites and full traffic analytics for Shanghai Majorbio Pharmaceutical Technology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 39 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shanghai Majorbio Pharmaceutical Technology
Shanghai Majorbio Pharmaceutical Technology was founded in 2009 and raised its 1st funding round 9 years after it was founded.
Shanghai Majorbio Pharmaceutical Technology is headquartered in Shanghai, China.
Ming Wei is the CEO of Shanghai Majorbio Pharmaceutical Technology, as recorded in our data.
Shanghai Majorbio Pharmaceutical Technology was founded in 2009 and is based in Shanghai, China. Operations focus on the life sciences sector, where high-throughput sequencing, biological information analysis, and research into clinical diagnostic kits are conducted. Genome sequencing services are extended to support pharmaceutical and biotechnology applications in the region.
Shanghai Majorbio Pharmaceutical Technology's top competitors include Novogene Corporation, BGI and HitGen.
Shanghai Majorbio Pharmaceutical Technology has 1 investor. Key investors include Tianjin Venture Capital.